COmpliance and Efficacy in Mono and Combination Tablet Study ATacand/Atacand Plus

A Study to Evaluate the Effectiveness and Safety of a Fixed Dose Combination of Azilsartan Medoxomil and Chlorthalidone in Patients With High Blood Pressure Who do Not Achieve Target Blood Pressure Following Treatment With Azilsartan Medoxomil Alone

NCT01456169 ·Status: COMPLETED ·Phase: PHASE3

Atacand Dose Ranging in Hypertensive Pediatric Subjects 1 Year to Less Than 6 Years of Age

NCT00244621 ·Status: COMPLETED ·Phase: PHASE3

Bioavailability Study of Candesartan Cilexetil 8mg Tablet Under Fasting Conditions

NCT02006589 ·Status: COMPLETED ·Phase: PHASE1

Bioavailability Study of Candesartan Cilexetil 16mg Tablet Under Fasting Conditions

NCT02006602 ·Status: COMPLETED ·Phase: PHASE1

A Relative Bioavailability Study of a Fixed Dose Combination (FDC) Tablets of GSK587323

NCT02094924 ·Status: COMPLETED ·Phase: PHASE1

The Clinical Study to Evaluate the Efficacy and Safety of Fimasartan in Patients With Mild to Moderate Essential Hypertension

NCT01135212 ·Status: COMPLETED ·Phase: PHASE3

Efficacy of Candesartan on Reducing Blood Pressure in Insulin-Resistant, Obese Patients With Hypertension.

NCT00775814 ·Status: COMPLETED ·Phase: PHASE4

A Study to Evaluate the Efficacy and Safety of Amlodipine Besylate and Candesartan Cilexetil in Essential Hypertension Patient Who Are Not Adequately Controlled With Amlodipine Besylate Monotherapy

NCT02368665 ·Status: COMPLETED ·Phase: PHASE3

Antihypertensive Efficacy and Safety of Candesartan/HCT 32/25 mg in Comparison With Individual Components and Placebo

NCT00434967 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Efficacy and Safety of Amlodipine Besylate and Candesartan Cilexetil in Essential Hypertension Patient Who Are Not Adequately Controlled With Candesartan Cilexetil Monotherapy

NCT02368652 ·Status: COMPLETED ·Phase: PHASE3

Study of Nifedipine GITS and Candesartan Combination Compared to Monotherapy in Patients With Essential Hypertension

NCT01303783 ·Status: COMPLETED ·Phase: PHASE2

Compliance of Patients With Essential Hypertension Treated With Candesartan or Candesartan/Hydrochlorothiazide

NCT00608153 ·Status: COMPLETED

Safety and Efficacy of Aliskiren + Hydrochlorothiazide (± Amlodipine 5 mg) in Patients With Moderate Hypertension

NCT00867490 ·Status: COMPLETED ·Phase: PHASE3

Atacand Dose Range Finding Study in Pediatric Subjects 6 to <17 Years of Age

NCT00244634 ·Status: COMPLETED ·Phase: PHASE3

A Dose Selection Trial of CKD-330 in Patients With Essential Hypertension

NCT02206165 ·Status: UNKNOWN ·Phase: PHASE2

Efficacy and Safety of Azilsartan Medoxomil Combined With Chlorthalidone in Participants With Moderate to Severe Hypertension

NCT00847626 ·Status: COMPLETED ·Phase: PHASE3

A Clinical Study to Evaluate Efficacy and Safety of Fimasartan/Hydrochlorothiazide Combination-therapy

NCT01258673 ·Status: COMPLETED ·Phase: PHASE3

Clinical Efficacy and Safety Evaluation of HCP1904-3 in Essential Hypertension Patients

NCT05199129 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Azilsartan in Participants With Mild to Moderate Uncomplicated Essential Hypertension

NCT01289132 ·Status: COMPLETED ·Phase: PHASE2

Study to Characterize the Long-term Clinical Experience of Atacand in Hypertensive Children Ages 1 to<11 Years (Hypertension in Pediatrics)

NCT00690612 ·Status: COMPLETED ·Phase: PHASE3

Evaluate Efficacy and Safety of Ezetimibe/Rosuvastatin and Candesartan Cilexetil/Amlodipine Besylate Combination Tablets

NCT03847506 ·Status: COMPLETED ·Phase: PHASE4

A Clinical Trial to Evaluate Efficacy, Tolerability, and Pharmacokinetic-Pharmacodynamic Relationship of Fimasartan/Hydrochlorothiazide

NCT02222480 ·Status: COMPLETED ·Phase: PHASE2

Double-Blind Randomized Cross-Over Trial Comparing Metabolic Effects of Candesartan, Hydrochlorothiazide and Placebo

NCT00282178 ·Status: COMPLETED ·Phase: PHASE2

High Doses of Candesartan Cilexetil on the Reduction of Proteinuria

NCT00242346 ·Status: COMPLETED ·Phase: PHASE3

Efficacy Observational Study of Candesartan Cilexetil on Hypertensive Patients

NCT00573742 ·Status: COMPLETED